Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
A phase 3b head-to-head study (SURMOUNT-5) in obesity without diabetes showed tirzepatide 10/15 mg achieved average weight loss of 20.2% after 72 weeks, versus 13.7% with semaglutide 2.4 mg
Wegovy (Obesity): FDA-approved in June 2021
While compounded semaglutide contains the same active ingredient as brand-name Wegovy or Ozempic, its quality can vary based on the pharmacys practices and the quality of the sourced ingredients
Supply Chain Disruptions Dr
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
